Pet Cancer Therapeutics Market By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Combination Therapy), By Pet Type (Dog, Cat and Others), By Mode of Administration (Oral, Topical, Intravenous), By Application (Lymphoma, Mast Cell Cancer, Melanoma, Mammary and Squamous Cell Cancer and Others) and By Region - Trends, Analysis and Forecast till 2034

The Pet Cancer Therapeutics Market size is estimated at USD 474.36 million in 2024, and is expected to reach USD 975.49 million by 2034, growing at a CAGR of 8.2% during the forecast period

In contrast to humans, many animal pet species, including dogs and cats, are prone to the same kinds of cancer. The number of mortality in dogs ten years of age and older is higher in cases of canine cancer. That being said, if caught early, almost half of all cancers in dogs can be cured. Pets with lymphoma, mast cell tumors, hemangiosarcoma, osteosarcoma, bladder cancer, brain tumor, mammary carcinoma, malignant histiocytosis, cancer of the mouth and nose, squamous cell carcinomas, and melanoma are among those with the highest incidence of cancer. Chemotherapy, radiation therapy, and surgery are the most often advised treatment modalities for cancer, either separately or in combination.